Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 10, 2011, Pages 1571-1580

  Kim, Jin C ^a,b   Lee, Han C ^b,c   Cho, Dong H ^b,d   Choi, Eun Y ^a,b   Cho, Yoon K ^a,b   Ha, Ye J ^a,b   Choi, Pyong W ^a,b   Roh, Seon A ^a,b   Kim, Seon Y ^b,c   Kim, Yong S ^b,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Chemosensitive marker; Colorectal cancer; Genome wide; Methylation; Targeted chemotherapy

Indexed keywords

BEVACIZUMAB; CASPASE 3; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; GENOMIC DNA; IRINOTECAN; OXALIPLATIN;

ADULT; ALX4 GENE; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL VIABILITY; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ESR1 GENE; FEMALE; GALR2 GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC SCREENING; GPX7 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IGFBP3 GENE; IN VITRO STUDY; KCNQ1 GENE; MALE; MMP25 GENE; NID2 GENE; ONCOGENE; ONCOGENE K RAS; PHARMACOGENETICS; PRIORITY JOURNAL; RASSF1 GENE; SCL18A2 GENE;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; RECEPTOR, GALANIN, TYPE 2; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 80054760182     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1036-7     Document Type: Article

References (31)

1. JH Bae J Schlessinger 2010 Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases Mol Cells 29 443 448 20432069 10.1007/s10059-010-0080-5 1:CAS:528:DC%2BC3cXmslShsbw%3D
2. M Bibikova E Chudin B Wu, et al. 2006 Human embryonic stem cells have a unique epigenetic signature Genome Res 16 1075 1083 16899657 10.1101/gr.5319906 1:CAS:528:DC%2BD28XpsFelsrw%3D (Pubitemid 44320394)
3. H Chang SY Rha HC Jeung, et al. 2010 Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells J Cancer Res Clin Oncol 136 1901 1913 20217129 10.1007/s00432-010-0849-0 1:CAS:528:DC%2BC3cXhtlaqtL%2FK
4. W Chung B Kwabi-Addo M Ittmann, et al. 2008 Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling PLoS One 3 e2079 18446232 10.1371/journal.pone.0002079 (Pubitemid 352025019)
5. MP Ebert F Model S Mooney, et al. 2006 Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas Gastroenterology 131 1418 1430 17101318 10.1053/j.gastro.2006.08.034 1:CAS:528:DC%2BD28XhtlantrbF (Pubitemid 44708938)
6. M Esteller J Garcia-Foncillas E Andion, et al. 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents N Engl J Med 343 1350 1354 11070098 10.1056/NEJM200011093431901 1:CAS:528:DC%2BD3cXosFOltLg%3D
7. R Fox M Aubert 2008 Flow cytometric detection of activated caspase-3 Methods Mol Biol 414 47 56 18175811 10.1007/978-1-59745-339-4-5 1:CAS:528:DC%2BD2sXhtlerurjF
8. G Gifford J Paul PA Vasey SB Kaye R Brown 2004 The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients Clin Cancer Res 10 4420 4426 15240532 10.1158/1078-0432.CCR-03- 0732 1:CAS:528:DC%2BD2cXlsVWlt7c%3D (Pubitemid 38878884)
9. RS Huang S Duan SJ Shukla, et al. 2007 Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach Am J Hum Genet 81 427 437 17701890 10.1086/519850 1:CAS:528:DC%2BD2sXhtVSqur3K (Pubitemid 47330203)
10. GD Hurlbut MW Kankel 2009 Artavanis-Tsakonas S. Nodal points and complexity of Notch-Ras signal integration Proc Natl Acad Sci USA 106 2218 2223 19171888 10.1073/pnas.0812024106 1:CAS:528:DC%2BD1MXitlaqtL4%3D
11. JP Issa 1999 Aging, DNA methylation and cancer Crit Rev Oncol Hematol 32 31 43 10586353 10.1016/S1040-8428(99)00019-0 1:STN:280:DC%2BD3c%2Flt1yjsg%3D%3D (Pubitemid 29486762)
12. AM Jubb AL Harris 2010 Biomarkers to predict the clinical efficacy of bevacizumab in cancer Lancet Oncol 11 1172 1183 21126687 10.1016/S1470-2045(10) 70232-1 1:CAS:528:DC%2BC3cXhsVyhsLbP
13. T Kanazawa K Misawa TE Carey 2010 Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma Expert Opin Ther Targets 14 289 302 20148716 10.1517/14728221003598922 1:CAS:528: DC%2BC3cXhvF2rsrg%3D
14. C Kelly J Cassidy 2007 Chemotherapy in metastatic colorectal cancer Surg Oncol 16 65 70 17521906 10.1016/j.suronc.2007.04.006
15. JC Kim SA Roh KH Lee H Namgung JR Kim JS Kim 2005 Genetic and pathologic changes associated with lymphovascular invasion of colorectal adenocarcinoma Clin Exp Metastasis 22 421 428 16283485 10.1007/s10585-005-1550-6 (Pubitemid 41609301)
16. JC Kim SY Kim DH Cho, et al. 2011 Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer Clin Cancer Res 17 1200 1209 21239504 10.1158/1078-0432.CCR-10-1907 1:CAS:528:DC%2BC3MXis1eit7w%3D
17. CH Köhne HJ Lenz 2009 Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer Oncologist 14 478 488 19411318 10.1634/theoncologist.2008-0202
18. C Li X Xu DK Nelson T Williams MR Kuehn CX Deng 2005 FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis Development 132 4755 4764 16207751 10.1242/dev.02065 1:CAS:528:DC%2BD2MXht12gsbnP (Pubitemid 41685285)
19. L Liu S Tommasi DH Lee R Dammann GP Pfeifer 2003 Control of microtubule stability by the RASSF1A tumor suppressor Oncogene 22 8125 8136 14603253 10.1038/sj.onc.1206984 1:CAS:528:DC%2BD3sXoslSisLo%3D (Pubitemid 37487303)
20. S Maier C Dahlstroem C Haefliger A Plum C Piepenbrock 2005 Identifying DNA methylation biomarkers of cancer drug response Am J Pharmacogenomics 5 223 232 16078859 10.2165/00129785-200505040-00003 1:CAS:528:DC%2BD2MXhtVGiu7zK (Pubitemid 43160337)
21. K Nosho N Irahara K Shima S Kure, et al. 2008 Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample PLoS One 3 e3698 19002263 10.1371/journal.pone.0003698
22. CJ Punt T Jolien 2009 More is less-combining targeted therapies in metastatic colorectal cancer Nat Rev Clin Oncol 6 731 733 19942926 10.1038/nrclinonc.2009.168 1:CAS:528:DC%2BD1MXhsVynur3P
23. JM Sargent 2003 The use of the MTT assay to study drug resistance in fresh tumour samples Recent Results Cancer Res 161 13 25 12528795 10.1007/978-3-642-19022-3-2 1:CAS:528:DC%2BD38XpsleksbY%3D
24. A Sartore-Bianchi K Bencardino A Cassingena, et al. 2010 Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer Cancer Treat Rev 36 S1 S5 21129603 10.1016/S0305-7372(10)70012-8 1:CAS:528:DC%2BC3MXis1agsw%3D%3D
25. H Sugawara K Iwamoto M Bundo J Ueda J Ishigooka T Kato 2011 Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines Epigenetics 6 508 515 21304276 10.4161/epi.6.4.14876
26. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D (Pubitemid 30099779)
27. WD Van Horn CG Vanoye CR Sanders 2011 Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel Curr Opin Struct Biol 21 283 291 21296569 10.1016/j.sbi.2011.01.001
28. N Yoshida K Ino Y Ishida, et al. 2008 Overexpression of indoleamine 2, 3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model Clin Cancer Res 14 7251 7259 19010841 10.1158/1078-0432.CCR-08-0991 1:CAS:528:DC%2BD1cXhtlylur7O
29. W Zhang ME Dolan 2009 Use of cell lines in the investigation of pharmacogenetic loci Curr Pharm Des 15 3782 3795 19925429 10.2174/ 138161209789649475 1:CAS:528:DC%2BD1MXhsFGht7rP
30. Z Zhang KG Neiva MW Lingen LM Ellis JE Nör 2010 VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2 Cell Death Differ 17 499 512 19834490 10.1038/cdd.2009.152 1:CAS:528: DC%2BC3cXhvFCrs7s%3D
31. H Zhao K Oka P Bringas V Kaartinen Y Chai 2008 TGF-beta type I receptor Alk5 regulates tooth initiation and mandible patterning in a type II receptor-independent manner Dev Biol 320 19 29 18572160 10.1016/j.ydbio.2008.03. 045 1:CAS:528:DC%2BD1cXptVCgurc%3D